RS58553B1 - Dijagnostika zatajenja srca - Google Patents
Dijagnostika zatajenja srcaInfo
- Publication number
- RS58553B1 RS58553B1 RS20190247A RSP20190247A RS58553B1 RS 58553 B1 RS58553 B1 RS 58553B1 RS 20190247 A RS20190247 A RS 20190247A RS P20190247 A RSP20190247 A RS P20190247A RS 58553 B1 RS58553 B1 RS 58553B1
- Authority
- RS
- Serbia
- Prior art keywords
- igfbp2
- heart failure
- patients
- concentration
- patient
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4745—Insulin-like growth factor binding protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/4473—Arrangements for investigating the separated zones, e.g. localising zones by electric means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
- Paper (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305988 | 2012-08-09 | ||
| PCT/EP2013/066697 WO2014023820A1 (en) | 2012-08-09 | 2013-08-09 | Diagnostic of heart failure |
| EP13747847.5A EP2883057B1 (en) | 2012-08-09 | 2013-08-09 | Diagnostic of heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS58553B1 true RS58553B1 (sr) | 2019-05-31 |
Family
ID=48953397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20190247A RS58553B1 (sr) | 2012-08-09 | 2013-08-09 | Dijagnostika zatajenja srca |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20150219669A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2883057B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6298054B2 (cg-RX-API-DMAC7.html) |
| CY (1) | CY1121406T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2883057T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2713098T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20190341T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE042708T2 (cg-RX-API-DMAC7.html) |
| LT (1) | LT2883057T (cg-RX-API-DMAC7.html) |
| PL (1) | PL2883057T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2883057T (cg-RX-API-DMAC7.html) |
| RS (1) | RS58553B1 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2883057T1 (cg-RX-API-DMAC7.html) |
| SM (1) | SMT201900108T1 (cg-RX-API-DMAC7.html) |
| TR (1) | TR201902555T4 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014023820A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3004891T3 (pl) * | 2013-06-06 | 2019-09-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarker ponownej hospitalizacji po niewydolności serca |
| JP7401442B2 (ja) * | 2018-01-31 | 2023-12-19 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 新規使用 |
| US20220390468A1 (en) * | 2019-11-06 | 2022-12-08 | National University Corporation Kagawa University | Heart failure marker |
| CN120053474B (zh) * | 2025-02-26 | 2025-12-12 | 浙江大学 | 辅酶a在制备心肌细胞铁死亡抑制剂中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060183681A1 (en) * | 2005-02-14 | 2006-08-17 | Bio-Rad Laboratories, Inc. | Stabilized compositions containing natriuretic peptides |
| JP4465469B2 (ja) * | 2005-02-21 | 2010-05-19 | 国立大学法人佐賀大学 | 循環器病マーカーとしてのインターロイキン１３ |
| EP1722232A1 (en) | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Devices and methods for diagnosing or predicting early stage cardiac dysfunctions |
| US20080166734A1 (en) * | 2005-12-21 | 2008-07-10 | David Xing-Fei Deng | Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease |
| US20080112888A1 (en) * | 2006-06-30 | 2008-05-15 | Schering Corporation | Igfbp2 biomarker |
| EP2498095A3 (en) | 2007-01-25 | 2012-11-28 | Roche Diagniostics GmbH | Use of IGFBP-7 in the assessment of heart failure |
| EP2310860A1 (en) * | 2008-07-30 | 2011-04-20 | INSERM - Institut National de la Santé et de la Recherche Médicale | Blood glutathione as a biomarker for screening asymptomatic patients at risk for heart failure |
| US20130345322A1 (en) * | 2010-07-14 | 2013-12-26 | Commonwealth Scientific And Industrial Research Organisation | Diagnostic for colorectal cancer |
| JP5676763B2 (ja) * | 2010-08-26 | 2015-02-25 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 動脈性高血圧症から心不全への初期移行の評価におけるバイオマーカーの使用 |
| WO2013163345A1 (en) | 2012-04-24 | 2013-10-31 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury |
| WO2014116708A1 (en) * | 2013-01-22 | 2014-07-31 | Singulex, Inc. | Endothelin in the diagnosis of cardiac disease |
-
2013
- 2013-08-09 LT LTEP13747847.5T patent/LT2883057T/lt unknown
- 2013-08-09 HR HRP20190341TT patent/HRP20190341T1/hr unknown
- 2013-08-09 SM SM20190108T patent/SMT201900108T1/it unknown
- 2013-08-09 JP JP2015525897A patent/JP6298054B2/ja not_active Expired - Fee Related
- 2013-08-09 RS RS20190247A patent/RS58553B1/sr unknown
- 2013-08-09 SI SI201331364T patent/SI2883057T1/sl unknown
- 2013-08-09 EP EP13747847.5A patent/EP2883057B1/en active Active
- 2013-08-09 US US14/419,566 patent/US20150219669A1/en not_active Abandoned
- 2013-08-09 PL PL13747847T patent/PL2883057T3/pl unknown
- 2013-08-09 ES ES13747847T patent/ES2713098T3/es active Active
- 2013-08-09 PT PT13747847T patent/PT2883057T/pt unknown
- 2013-08-09 DK DK13747847.5T patent/DK2883057T3/en active
- 2013-08-09 HU HUE13747847A patent/HUE042708T2/hu unknown
- 2013-08-09 TR TR2019/02555T patent/TR201902555T4/tr unknown
- 2013-08-09 WO PCT/EP2013/066697 patent/WO2014023820A1/en not_active Ceased
-
2018
- 2018-01-12 US US15/869,438 patent/US11061037B2/en active Active
- 2018-02-22 JP JP2018029702A patent/JP6595641B2/ja active Active
-
2019
- 2019-02-25 CY CY20191100229T patent/CY1121406T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6298054B2 (ja) | 2018-03-20 |
| TR201902555T4 (tr) | 2019-03-21 |
| US11061037B2 (en) | 2021-07-13 |
| LT2883057T (lt) | 2019-04-25 |
| US20150219669A1 (en) | 2015-08-06 |
| SI2883057T1 (sl) | 2019-07-31 |
| PT2883057T (pt) | 2019-03-06 |
| JP6595641B2 (ja) | 2019-10-23 |
| CY1121406T1 (el) | 2020-05-29 |
| HUE042708T2 (hu) | 2019-07-29 |
| EP2883057A1 (en) | 2015-06-17 |
| EP2883057B1 (en) | 2018-12-05 |
| JP2018109640A (ja) | 2018-07-12 |
| JP2015528562A (ja) | 2015-09-28 |
| ES2713098T3 (es) | 2019-05-17 |
| HRP20190341T1 (hr) | 2019-05-31 |
| WO2014023820A1 (en) | 2014-02-13 |
| PL2883057T3 (pl) | 2019-07-31 |
| SMT201900108T1 (it) | 2019-05-10 |
| US20180143208A1 (en) | 2018-05-24 |
| DK2883057T3 (en) | 2019-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4944185B2 (ja) | 症状のある患者における急性および慢性の心筋壊死の区別のための手段と方法 | |
| CN109564225B (zh) | 作为指示不良事件的标志物的组蛋白和/或proADM | |
| CN102652261B (zh) | 用于预测心脏手术患者中的肾衰竭的gdf-15和/或肌钙蛋白t | |
| US20110104813A1 (en) | Diagnosis of early stage cardiac dysfunction | |
| Berry et al. | Proteomics analysis reveals IGFBP2 as a candidate diagnostic biomarker for heart failure | |
| US11061037B2 (en) | Diagnostic of heart failure | |
| US20220178945A1 (en) | Novel aortic aneurysm marker | |
| CN105102984B (zh) | sCD14或它的片段或衍生物用于风险分级、诊断和预后的用途 | |
| AU2014343709B2 (en) | Biomarkers and methods for progression prediction for chronic kidney disease | |
| WO2010043393A1 (en) | Use of biglycan in the assessment of heart failure | |
| US10557860B2 (en) | Circulating pulmonary hypertension biomarker | |
| Szatko et al. | Advances in the biochemical diagnostics of primary aldosteronism: from immunoassays to steroidomics and proteomics | |
| JP2010528306A (ja) | 心筋梗塞の早期予測因子としてのｈ−ｆａｂｐ | |
| JP5307141B2 (ja) | 心筋梗塞の早期予測因子としてのミオグロビン | |
| JP2011523072A (ja) | １型糖尿病を有する患者の合併症の評価 | |
| WO2009138466A2 (en) | Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use | |
| KR20160137859A (ko) | 당뇨병에 대한 신규 바이오마커 및 그의 용도 | |
| Koukoui et al. | IJC Metabolic & Endocrine | |
| WO2014177701A1 (en) | Process for diagnosing a human subject with diseases affecting the kidneys, or at risk of acquiring diseases affecting the kidneys | |
| Ucciferri et al. | Differential proteome profile in ischemic heart disease: Prognostic value in chronic angina versus myocardial infarction. A proof of concept | |
| WO2016113719A1 (en) | Use of 1,25-dihydroxyvitamin d values in ratio with pth as a prognostic biomarker | |
| HK1119771B (en) | Devices and methods for diagnosing or predicting early stage cardiac dysfunctions |